Khadija Benlhassan

Khadija Benlhassan is a highly accomplished immunologist who has held several key positions at ImmunoClin Corporation, including Director, Board Member, and Chief Scientific Officer.2

Education and Expertise

Dr. Benlhassan holds a PhD from Université René Descartes (Paris V) and a Master's degree from Université Joseph Fourier in France. Her expertise lies in immunology, covering various fields such as research and development, project management, and corporate strategy.

Professional Experience

Throughout her career, Dr. Benlhassan has worked in several prominent roles:

• Senior Research Scientist at GSK
• Project Manager in Immunology at Danone
• R&D Project Director at Mercuria
• Founder and President of KB Healthcare SASU
• Director, Board Member, and Chief Scientific Officer at ImmunoClin Corporation
• R&D Program Leader at ImmunoClin3

Contributions and Skills

As a highly experienced scientist, Dr. Benlhassan has demonstrated expertise in:

• Designing, conducting, and analyzing experiments
• Publishing papers in peer-reviewed journals
• Presenting research findings at international conferences
• Managing multiple projects, particularly in developing new nutritional products for gut health and baby nutrition

Role at ImmunoClin Corporation

At ImmunoClin Corporation, Dr. Benlhassan played a crucial role in the company's scientific direction and operations. In 2015, she was involved in relocating the company's European headquarters and laboratories to London, UK.4 Her responsibilities included overseeing the company's scientific initiatives and contributing to its strategic decisions as a board member.1

Dr. Khadija Benlhassan's extensive experience and accomplishments in the field of immunology have made her a valuable asset to ImmunoClin Corporation and the broader scientific community.